Methylprednisolone Acetate Powder
NDC Package 60722-1007-2

View Billable Units, 11-Digit Conversion Format, and RxNorm mappings
Table of Contents
    1. Package Information
    2. Other Packages
    3. Frequently Asked Questions

Package Information

This product is an UNFINISHED DRUG part of the official NDC directory. Unfinished drugs include products like active ingredients some of which are used in bulk for further processing or compounding. The FDA requires a list of these drugs manufactured in a U.S. commercial distribution facility.

Methylprednisolone Acetate powders is methylprednisolone is used to treat pain and swelling that occurs with arthritis and other joint disorders. This formulation utilizes a powder delivery system. Marketed by Zhejiang Xianju Pharmaceutical Co., Ltd., this product is identified by NDC 60722-1007.

Identification & Billing

NDC Package Code
60722-1007-2
Package Description
2.5 kg in 1 DRUM
Product Code
60722-1007
11-Digit Billing Format
60722100702

Clinical Specifications

Proprietary Name
Methylprednisolone Acetate
Non-Proprietary Name
Methylprednisolone Acetate
Substance Name
Methylprednisolone Acetate
Dosage Form
Powder - An intimate mixture of dry, finely divided drugs and/or chemicals that may be intended for internal or external use.
Active Ingredient(s)
METHYLPREDNISOLONE ACETATE 1 kg/kg
Usage Information
Methylprednisolone is used to treat pain and swelling that occurs with arthritis and other joint disorders. This medication may also be used to treat various conditions such as blood disorders, severe allergic reactions, certain cancers, eye conditions, skin/intestinal/kidney/lung diseases, and immune system disorders. It decreases your immune system's response to these conditions and reduces symptoms such as swelling, pain, and allergic-type reactions. Talk to your doctor about the risks and benefits of methylprednisolone, especially if it is to be injected near your spine (epidural). Rare but serious side effects may occur with epidural use. Methylprednisolone is a corticosteroid hormone. Methylprednisolone may also be used with other medications in hormone disorders.

Regulatory & Marketing

Labeler Name
Zhejiang Xianju Pharmaceutical Co., Ltd.
Product Type
Bulk Ingredient
Marketing Category
BULK INGREDIENT - A category specifying that a product is marketed as a bulk ingredient.
Start Marketing Date
02-21-2017
Listing Expiration
12-31-2026
Exclude Flag
N
Unfinished Product
Yes
Sample Package
N/A

Hierarchy Structure

Code Lineage

The NDC Directory contains ONLY information on final marketed drugs submitted to FDA electronically by labelers. A labeler might be a manufacturer, re-packager or re-labeler. The product information included in the NDC directory does not indicate that FDA has verified the information provided by the product labeler. Assigned NDC numbers are not in any way an indication of FDA approval of the product.

* Please review the full disclaimer at the bottom of this page.

Other Available Packages

The following commercial packages are registered under the same Product NDC (60722-1007). Click a package code to view its specific billing and regulatory data.

60722-1007-1
5 kg in 1 DRUM

* Please review the full disclaimer at the bottom of this page.

Frequently Asked Questions

What is the distribution configuration for this product package?

The code 60722-1007-2 identifies a specific commercial package of 2.5 kg in 1 drum of Methylprednisolone Acetate (UNFINISHED drug), a bulk ingredient labeled by Zhejiang Xianju Pharmaceutical Co., Ltd.. This powder is formulated for use and contains methylprednisolone acetate as the active substance.

Is this product currently listed with the FDA?

Yes, this product is active and verified within the NDC Directory. It was introduced to the market by Zhejiang Xianju Pharmaceutical Co., Ltd. on February 21, 2017. The current certification is valid through December 31, 2026.

What are the primary indications for this medication?

Methylprednisolone is used to treat pain and swelling that occurs with arthritis and other joint disorders. This medication may also be used to treat various conditions such as blood disorders, severe allergic reactions, certain cancers, eye conditions, skin/intestinal/kidney/lung diseases, and immune system disorders. It decreases your immune system's response to these conditions and reduces symptoms such as swelling, pain, and allergic-type reactions. Talk to your doctor about the risks and benefits of methylprednisolone, especially if it is to be injected near your spine (epidural). Rare but serious side effects may occur with epidural use. Methylprednisolone is a corticosteroid hormone. Methylprednisolone may also be used with other medications in hormone disorders.

How is this Zhejiang Xianju Pharmaceutical Co., Ltd. product billed for insurance claims?

For medical billing and reimbursement, this package follows the 11-digit CMS format: 60722100702. The table below illustrates the segment conversion from the 10-digit labeler code to the 11-digit provider format.

11-Digit Code Conversion

Billing payers usually require a 5-4-2 segment configuration. Below is the conversion from the 10-digit package format to the 11-digit billing format:

10-Digit Format (5-4-1)
60722-1007-2
11-Digit CMS (5-4-2)
60722-1007-02

Note: The zero is added to the Package segment to maintain the 5-4-2 structure.